EnGene (NASDAQ: ENGN) stock suffered a more-than-80% plunge this past week that reflects just how competitive the field is ...

A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

There is no margin for error in the pharma and biopharma sectors. If the chain-identity breaks anywhere along the way, there ...

For the second year in a row, GEN spoke with David Barrett, JD, who has been the CEO of ASGCT since 2016. In this interview, ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Enein, MD, PhD, for a measurement-driven approach that advances cell therapy translation, from high-dimensional analytics to ...

Macrophages use cell‑volume changes to sense danger, reprogram gene expression, and heighten inflammatory and antiviral responses.

Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...

The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

There has been widespread success in treating blood cancers, while progress in solid tumors has been more limited.